Evidence map›Paper›PMID 30092180›Full record

ReviewEuropean journal of pharmacology2018

Neuropharmacology of attention.

Joshua A Burk, Sarah A Blumenthal, Eden B Maness

Open access · greenAbstract readReview
In one paragraph

Review in European journal of pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The Many Roles of Precision in Action.Entropy (Basel, Switzerland) · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Joshua A BurkDepartment of Psychological Sciences, College of William and Mary, Williamsburg, VA 23187, USA. Electronic address: jabur2@wm.edu.
Sarah A BlumenthalDepartment of Psychological Sciences, College of William and Mary, Williamsburg, VA 23187, USA.
Eden B ManessDepartment of Psychological Sciences, College of William and Mary, Williamsburg, VA 23187, USA.
William & Mary · US

Funding

Hypocretin/orexin modulation of cognitive correlates of brain agingR01AG050518 · NIA · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI JIM R FADEL · 2015 to 2026
$2.1M
Hypocretin/orexin modulation of cognitive correlates of brain agingRF1AG050518 · NIA · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI FADEL, JIM R · 2022 to 2022
$1.1M
NIA NIH HHS R01 AG050518NIA NIH HHS RF1 AG050518
6 · The paper itself

Abstract

Early philosophers and psychologists defined and began to describe attention. Beginning in the 1950's, numerous models of attention were developed. This corresponded with an increased understanding of pharmacological approaches to manipulate neurotransmitter systems. The present review focuses on the knowledge that has been gained about these neurotransmitter systems with respect to attentional processing, with emphasis on the functions mediated within the medial prefrontal cortex. Additionally, the use of pharmacotherapies to treat psychiatric conditions characterized by attentional dysfunction are discussed. Future directions include developing a more comprehensive understanding of the neural mechanisms underlying attentional processing and novel pharmacotherapeutic targets for conditions characterized by aberrant attentional processing.

Indexed as

AnimalsAttentionHumansNeuropharmacologyAttentionNeurotransmitterPrefrontal cortexVigilance

Identifiers

PMID30092180
PMCPMC6140347
OpenAlexW2887887884

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.